OR WAIT null SECS
April 16, 2009
Also, Sanofi-aventis acquires Medley and Laboratorios Kendrick; Eli Lilly's Cook to retire from board; more...
April 09, 2009
Also, Genzyme and Bayer HealthCare form agreement; FDA releases draft guidances; TransMolecular appointed Robert Radie president and CEO
April 02, 2009
Also, SOCMA changes name; two FDA approvals; Biogen Idec names chief operating officer; more...
Obama's cost-containment and science-innovation initiatives need to overlap.
A review of recent product innovations, policy developments, and growth prospects in the excipients market.
A Position Paper from the AAPS In Vitro Release and Dissolution Focus Group
The financial and economic downturn is likey to have long-term implications for outsourcing.
April 01, 2009
The authors demonstrate how melt-extrusion and spray-drying methods can help to prepare solid dispersions of poorly soluble drugs using Eudragit polymers.
The authors examine common superdisintegrants (i.e., crospovidone Type A, crospovidone Type B, croscarmellose sodium, and sodium starch glycolate) with a set of poorly soluble drug actives and evaluate in vitro drug dissolution.
The authors examine the use of a novel highly functional pregelatinized starch as a controlled-release matrix excipient.